sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> brain cancer diagnostics market

report

Brain Cancer Diagnostics Market, by Test Types (Magnetic Resonance Spectroscopy, PET Scan, Single Photon Emission CT Scan ,Spinal Tap, Magnetic Resonance Imaging), Brain Cancer Types (Acoustic Neuroma, Astrocytomas, Chordomas, Choroid Plexus Papilloma, Craniopharyngiomas, Other Brain Cancers), End-users (Hospitals, Cancer Research Institutes, Cancer Diagnostic Centers) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC226 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the brain cancer diagnostics market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the brain cancer diagnostics market. The scope of this report covers the brain cancer diagnostics market by its major segments, which include the test types, brain cancer types, end-users, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The rapid technological advancements are some of the key factors driving the revenue of the brain cancer diagnostics market during the forecast period.
  • Additionally, the increasing prevalence of brain cancer, environmental toxins, and cigarette smoking are some of the factors expected to fuel the market growth.
  • However, the low awareness and high cost associated with treatment are likely to hamper the growth of the brain cancer diagnostics market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s brain cancer diagnostics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the brain cancer diagnostics market by the following segments:

  • Brain Cancer Diagnostics Market, by Test Types
    • Magnetic Resonance Spectroscopy
    • PET Scan
    • Single Photon Emission CT Scan
    • Spinal Tap
    • Magnetic Resonance Imaging
  • Brain Cancer Diagnostics Market, by Brain Cancer Types
    • Acoustic Neuroma
    • Astrocytomas
    • Chordomas
    • Choroid Plexus Papilloma
    • Craniopharyngiomas
    • Other Brain Cancers
  • Brain Cancer Diagnostics Market, by End-users
    • Hospitals
    • Cancer Research Institutes
    • Cancer Diagnostic Center

KEY MARKET PLAYERS

Key players in the brain cancer diagnostics market include:

  • Thermo Fisher Scientific, Inc.
  • General Electric Company
  • Siemens Healthcare GmbH 
  • Shimadzu Corporation
  • Koninklijke Philips N.V.
  • TOSHIBA CORPORATION
  • Hitachi, Ltd
  • Carestream Health
  • Hologic, Inc.
  • Fujifilm Corporation

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Brain Cancer Diagnostics Market

TRENDING RELATED REPORT


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. BRAIN CANCER DIAGNOSTICS MARKET, BY TEST TYPES
    1. Segment Share
    2. Test Types
      1. Magnetic Resonance Spectroscopy
      2. PET Scan
      3. Single Photon Emission CT Scan
      4. Spinal Tap
      5. Magnetic Resonance Imaging
  6. BRAIN CANCER DIAGNOSTICS MARKET, BY BRAIN CANCER TYPES
    1. Segment Share
    2. Brain Cancer Types
      1. Acoustic Neuroma
      2. Astrocytomas
      3. Chordomas
      4. Choroid Plexus Papilloma
      5. Craniopharyngiomas
      6. Other Brain Cancers
  7. BRAIN CANCER DIAGNOSTICS MARKET, BY END-USERS
    1. Segment Share
    2. End-users
      1. Hospitals
      2. Cancer Research Institutes
      3. Cancer Diagnostic Center
  8. BRAIN CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Test Types
      3. By Brain Cancer Types
      4. By End-users
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Test Types
      3. By Brain Cancer Types
      4. By End-users
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Test Types
      3. By Brain Cancer Types
      4. By End-users
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Test Types
      3. By Brain Cancer Types
      4. By End-users
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. General Electric Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Siemens Healthcare GmbH 
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Shimadzu Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Koninklijke Philips N.V.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. TOSHIBA CORPORATION
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Hitachi, Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Carestream Health
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Hologic, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Fujifilm Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us